INTERNATIONAL PATENT: TANEA MEDICAL AB FILES APPLICATION FOR "NOVEL ENGINEERED STREPTOLYSIN O DERIVED EPITOPES"

GENEVA, April 19 -- TANEA MEDICAL AB (Bangardsgatan 13753 20 Uppsala) filed a patent application (PCT/EP2024/078624) for "NOVEL ENGINEERED STREPTOLYSIN O DERIVED EPITOPES" on Oct 11, 2024. With publication no. WO/2025/078558, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MALMSTROM, Anders Johan (Lund University, Department of Clinical Sciences, LundDivision of Infection MedicineBMC, D13221 84 Lund), MALMSTROM, Lars Gustav (Lund University, Department of Clinical Sciences, LundDivision of Infection MedicineBMC, D13221 84...